Cargando…
Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has dramatically impacted global health, and patients with type 2 diabetes have been identified as a high-risk group for COVID-19 infection and the development of severe disease. In response, this study aimed to evaluate whether patients w...
Autores principales: | Otsubo, Naoya, Fukuda, Tatsuya, Beppu, Hiroko, Maki, Chisato, Yasui, Fumihiko, Hanawa, Tomohide, Sugita, Chise, Murakami, Masanori, Yamada, Tetsuya, Kohara, Michinori, Wakai, Sachiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816526/ https://www.ncbi.nlm.nih.gov/pubmed/36604681 http://dx.doi.org/10.1186/s12902-023-01263-z |
Ejemplares similares
-
Hemodialysis patients with coronavirus disease 2019: reduced antibody response
por: Beppu, Hiroko, et al.
Publicado: (2021) -
Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes
por: Fukuda, Tatsuya, et al.
Publicado: (2023) -
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection
por: Beppu, Hiroko, et al.
Publicado: (2022) -
Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
por: Yasui, Fumihiko, et al.
Publicado: (2014) -
Corrigendum to ‘Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus’ [Virology (2014) 157–168]
por: Yasui, Fumihiko, et al.
Publicado: (2016)